What to expect from immunotherapy for non-small cell lung cancer

Immunotherapy helps immune cells recognise and attack non-small cell lung cancer cells. It may be used alone or with another treatment, based on tumour features, disease extent, previous care, and your general health. Many medicines are given through an intravenous infusion at a clinic. The team will explain the schedule, observation, blood tests, and imaging used to assess response. A temporary symptom change does not by itself prove that treatment is helping or harming you.

Provide a complete list of medicines and supplements, and mention autoimmune conditions, allergies, organ problems, or past treatment reactions. Track cough, breathing, bowel movements, rash, fever, pain, appetite, and energy between visits. Keep your cancer team’s contact details nearby. Attend planned blood tests and scans, and check before taking a new medicine or vaccine because the care team may need to coordinate it.

Contact your oncology team promptly for a new or worsening cough, breathlessness, chest pain, fever, severe diarrhoea, persistent vomiting, rash, vision change, confusion, or yellowing of the skin. Seek emergency care for severe breathing difficulty, fainting, sudden confusion, or severe chest pain. Immune-related inflammation can affect the lungs and other organs, and early assessment helps prevent a manageable problem from becoming more serious.

Ask which tumour tests guide the choice, whether immunotherapy is combined with another treatment, how long visits may take, and how response will be assessed. Ask which symptoms need a same-day call and what happens if treatment must be delayed or paused.